Review: systemic inflammation and Alzheimer's disease
- PMID: 23046210
- DOI: 10.1111/j.1365-2990.2012.01307.x
Review: systemic inflammation and Alzheimer's disease
Abstract
There is a great deal of evidence suggesting an important role for systemic inflammation in the pathogenesis of Alzheimer's disease. The role of systemic inflammation, and indeed inflammation in general, is still largely considered to be as a contributor to the disease process rather than of aetiological importance although there is emerging evidence to suggest that its role may predate the deposition of amyloid. Therapies aimed at reducing inflammation in individuals with mild cognitive impairment and Alzheimer's disease have been disappointing and have largely focused on the need to ameliorate central inflammation with little attention to the importance of dampening down systemic inflammation. Novel approaches in this area require a greater understanding of the effects of systemic inflammation on the development and progression of Alzheimer's disease and of the communicating pathways between the systemic and central innate immune systems.
© 2012 The Author. Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society.
Similar articles
-
Systemic inflammation and Alzheimer's disease.Biochem Soc Trans. 2011 Aug;39(4):898-901. doi: 10.1042/BST0390898. Biochem Soc Trans. 2011. PMID: 21787320
-
Inflammation and therapeutic vaccination in CNS diseases.Nature. 2002 Dec 19-26;420(6917):879-84. doi: 10.1038/nature01325. Nature. 2002. PMID: 12490962 Review.
-
Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.Neuroimmunomodulation. 2014;21(2-3):79-87. doi: 10.1159/000356529. Epub 2014 Feb 14. Neuroimmunomodulation. 2014. PMID: 24557039 Review.
-
Inflammation and Alzheimer's disease.Int J Clin Pract. 2003 Jan-Feb;57(1):36-9. Int J Clin Pract. 2003. PMID: 12587940 Review.
-
Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.Exp Neurol. 1998 Nov;154(1):89-98. doi: 10.1006/exnr.1998.6920. Exp Neurol. 1998. PMID: 9875271 Review.
Cited by
-
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.Alzheimers Dement (Amst). 2016 Jul 9;3:103-9. doi: 10.1016/j.dadm.2016.06.005. eCollection 2016. Alzheimers Dement (Amst). 2016. PMID: 27453932 Free PMC article.
-
Potential Bidirectional Relationship Between Periodontitis and Alzheimer's Disease.Front Physiol. 2020 Jul 3;11:683. doi: 10.3389/fphys.2020.00683. eCollection 2020. Front Physiol. 2020. PMID: 32719612 Free PMC article. Review.
-
Apigenin attenuates serum concentrations of TNF-a, interleukin 1b and interleukin 6 in lipopolysaccharide-stimulated rats.Avicenna J Phytomed. 2024 Jul-Aug;14(4):415-421. doi: 10.22038/AJP.2023.23365. Avicenna J Phytomed. 2024. PMID: 38952770 Free PMC article.
-
Environmental, Sociocultural, Behavioral, and Biological Factors Associated with Cognitive Decline, Alzheimer's Disease, and Other Types of Dementia in Black Americans.Curr Epidemiol Rep. 2023 Dec;10(4):252-263. doi: 10.1007/s40471-023-00337-9. Epub 2023 Nov 14. Curr Epidemiol Rep. 2023. PMID: 39206249 Free PMC article.
-
Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans.Sci Rep. 2016 Oct 6;6:34477. doi: 10.1038/srep34477. Sci Rep. 2016. PMID: 27708338 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical